AIM IMMUNOTECH INC. (AIM) Operating income 2016–2025
AIM IMMUNOTECH INC. (AIM) annual operating income history from SEC filings — each fiscal year as reported.
-$11.7MFY2025 · since FY2016: -$13.8M → -$11.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.7M | +41.0% |
| FY2024 | -$19.8M | +38.0% |
| FY2023 | -$31.9M | -60.2% |
| FY2022 | -$19.9M | -5.8% |
| FY2021 | -$18.8M | -24.3% |
| FY2020 | -$15.2M | -21.8% |
| FY2019 | -$12.4M | -8.2% |
| FY2018 | -$11.5M | -0.7% |
| FY2017 | -$11.4M | +17.3% |
| FY2016 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice